Physician Self Disclosure of IUC Use

Pilot Study of Physician Self-disclosure of Personal Intrauterine Contraceptive Use Versus Usual Counseling

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01994356

Enrollment

132

Registered

2013-11-25

Start date

2011-01-31

Completion date

2013-02-28

Last updated

2013-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Contraceptive counseling, Physician self disclosure, Satisfaction, Intrauterine contraceptive use

Brief summary

As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.

Detailed description

We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.

Interventions

BEHAVIORALPhysician self-disclosure of personal IUC use

Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling

BEHAVIORALUsual contraceptive counseling

all subjects recieved usual contraceptive counseling

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 44 Years

Healthy volunteers

Inclusion criteria

* reproductive age * currently sexually active * scheduled for benign gynecology visit, annual exam, or family planning visit

Exclusion criteria

* seeking pregnancy within 1 year * currently using IUC * prior sterilization procedure * currently pregnant

Design outcomes

Primary

Measure	Time frame	Description
Intrauterine contraceptive use	immediately following clinical encounter and at 2 months	All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.

Secondary

Measure	Time frame	Description
Satisfaction with clinical encounter	immediately following clinical encounter and at 2 months	All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.

Other

Measure	Time frame	Description
Satisfaction with provider	immediately following clinical encounter and at 2 months	All subjects were surveyed to determine satisfaction with their provider immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.
Satisfaction with contraceptive method	immediately following clinical enocunter and at 2 months	All subjects were surveyed to determine satisfaction with their contraceptive method of choice immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026